Dummy Run of Quality Assurance Program in a Phase 3 Randomized Trial Investigating the Role of Internal Mammary Lymph Node Irradiation in Breast Cancer Patients: Korean Radiation Oncology Group 08-06 Study

被引:18
作者
Chung, Yoonsun [1 ]
Kim, Jun Won [2 ]
Shin, Kyung Hwan [3 ]
Kim, Su Ssan [4 ]
Ahn, Sung-Ja [5 ]
Park, Won [6 ]
Lee, Hyung-Sik [7 ]
Kim, Dong Won [8 ]
Lee, Kyu Chan [9 ]
Suh, Hyun Suk [10 ]
Kim, Jin Hee [11 ]
Shin, Hyun Soo [12 ]
Kim, Yong Bae [1 ]
Suh, Chang-Ok [1 ]
机构
[1] Yonsei Univ, Yonsei Canc Ctr, Dept Radiat Oncol, Coll Med, Seoul 120752, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Dept Radiat Oncol, Coll Med, Seoul 120752, South Korea
[3] Natl Canc Ctr, Res Inst & Hosp, Proton Therapy Ctr, Dept Radiat Oncol, Goyang, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[5] Chonnam Natl Univ, Sch Med, Dept Radiat Oncol, Kwangju, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[7] Dong A Univ, Dong A Univ Hosp, Sch Med, Dept Radiat Oncol, Pusan, South Korea
[8] Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Radiat Oncol, Pusan, South Korea
[9] Gachon Univ, Gil Med Ctr, Dept Radiat Oncol, Inchon, South Korea
[10] Ewha Womans Univ, Mokdong Hosp, Dept Radiat Oncol, Seoul, South Korea
[11] Keimyung Univ, Sch Med, Dept Radiat Oncol, Dongsan Med Ctr, Taegu, South Korea
[12] CHA Univ, Sch Med, Dept Radiat Oncol, Bundang CHA Hosp, Songnam, South Korea
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 91卷 / 02期
关键词
EORTC RADIOTHERAPY GROUP; STAGE-I; ADJUVANT RADIOTHERAPY; CHAIN;
D O I
10.1016/j.ijrobp.2014.10.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The Korean Radiation Oncology Group (KROG) 08-06 study protocol allowed radiation therapy (RT) technique to include or exclude breast cancer patients from receiving radiation therapy to the internal mammary lymph node (IMN). The purpose of this study was to assess dosimetric differences between the 2 groups and potential influence on clinical outcome by a dummy run procedure. Methods and Materials: All participating institutions were asked to produce RT plans without irradiation (Arm 1) and with irradiation to the IMN (Arm 2) for 1 breast-conservation treatment case (breast-conserving surgery [BCS]) and 1 mastectomy case (modified radical mastectomy [MRM]) whose computed tomography images were provided. We assessed interinstitutional variations in IMN delineation and evaluated the dose-volume histograms of the IMN and normal organs. A reference IMN was delineated by an expert panel group based on the study guidelines. Also, we analyzed the potential influence of actual dose variation observed in this study on patient survival. Results: Although physicians intended to exclude the IMN within the RT field, the data showed almost 59.0% of the prescribed dose was delivered to the IMN in Arm 1. However, the mean doses covering the IMN in Arm 1 and Arm 2 were significantly different for both cases (P<. 001). Due to the probability of overdose in Arm 1, the estimated gain in 7-year disease-free survival rate would be reduced from 10% to 7.9% for BCS cases and 7.1% for MRM cases. The radiation doses to the ipsilateral lung, heart, and coronary artery were lower in Arm 1 than in Arm 2. Conclusions: Although this dummy run study indicated that a substantial dose was delivered to the IMN, even in the nonirradiation group, the dose differences between the 2 groups were statistically significant. However, this dosimetric profile should be studied further with actual patient samples and be taken into consideration when analyzing clinical outcomes according to IMN irradiation. (C) 2015 Elsevier Inc.
引用
收藏
页码:419 / 426
页数:8
相关论文
共 21 条
  • [11] Marinus A, 2002, EUR J CANCER, V38, pS159
  • [12] Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group
    Nielsen, Mette H.
    Berg, Martin
    Pedersen, Anders N.
    Andersen, Karen
    Glavicic, Vladimir
    Jakobsen, Erik H.
    Jensen, Ingelise
    Josipovic, Mirjana
    Lorenzen, Ebbe L.
    Nielsen, Hanne M.
    Stenbygaard, Lars
    Thomsen, Mette S.
    Vallentin, Susanne
    Zimmermann, Sune
    Offersen, Birgitte V.
    [J]. ACTA ONCOLOGICA, 2013, 52 (04) : 703 - 710
  • [13] Postmastectomy radiotherapy of the chest wall: Dosimetric comparison of common techniques
    Pierce, LJ
    Butler, JB
    Martel, MK
    Normolle, DP
    Koelling, T
    Marsh, RB
    Lichter, AS
    Fraass, BA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (05): : 1220 - 1230
  • [14] Poortmans P, 2013, EUR J CANCER, V49, pS1
  • [15] Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I-III breast cancer: the individual case review
    Poortmans, P
    Kouloulias, VE
    Venselaar, JL
    Struikmans, H
    Davis, JB
    Huyskens, D
    van Tienhoven, G
    Hurkmans, C
    Mijnheer, B
    Van den Bogaert, W
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (14) : 2035 - 2042
  • [16] Poortmans P, 2006, STRAHLENTHER ONKOL, V182, P576, DOI 10.1007/s00066-006-1629-2
  • [17] The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: A quality-assurance report on the dummy run of EORTC phase III randomized trial 22922/10925 in stage I-III breast cancer
    Poortmans, PMP
    Venselaar, JLM
    Struikmans, H
    Hurkmans, CW
    Davis, JB
    Huyskens, D
    van Tienhoven, G
    Vlaun, V
    Lagendijk, JJW
    Mijnheer, BJ
    De Winter, KA
    Van der Hulst, MH
    Van den Bogaert, WFC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (05): : 1399 - 1408
  • [18] Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based
    Taghian, A
    Jagsi, R
    Makris, A
    Goldberg, S
    Ceilley, E
    Grignon, L
    Powell, S
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03): : 706 - 714
  • [19] Therasse P, 2002, EUR J CANCER, V38, pS151
  • [20] EORTC RADIOTHERAPY GROUP QUALITY ASSURANCE - MECHANICAL CHECKS AND BEAM ALIGNMENTS OF MEGAVOLTAGE EQUIPMENT
    VANDAM, J
    JOHANSSON, KA
    BRIDIER, A
    SERNBO, G
    HANSSON, U
    [J]. RADIOTHERAPY AND ONCOLOGY, 1993, 29 (02) : 91 - 96